GSK Shingrix Shingles Vaccine Seen Displacing Zostavax After US FDA Approval
US FDA OK for its two-shot shingles regime gives GSK a likely blockbuster with a clear best-in-class profile.
US FDA OK for its two-shot shingles regime gives GSK a likely blockbuster with a clear best-in-class profile.